News
First, HDA appointed two new members to its Executive Committee and Board of Directors:
“I welcome Debbie and Rich into their new roles, while thanking Bob for his years of service to HDA and the industry,” said Chester “Chip” Davis, Jr., President and CEO, HDA. “I look forward to working with the full Board of Directors as we execute against HDA’s strategic priorities. Working together, we will help ensure the safe and reliable distribution of medicines, vaccines and healthcare products to all Americans.”
The HDA Board of Directors is led by Chairman Chad Gielen of Louisiana Wholesale Drug Company and Vice Chairman Kirk Kaminsky of McKesson. View a full list of HDA directors here.
Second, the HDA Executive Committee approved four new appointments to the HDA Research Foundation Board of Directors:
Craig Cowman, Executive Vice President, Strategic Sourcing and Manufacturer Services, Cardinal Health, will continue as the HDA Research Foundation’s Chairman in 2023, with Steve Giuli, Vice President, Government Affairs and Trade Relations, Apotex Corp., serving as Vice Chairman. View a full list of Foundation directors here.
HDA and the HDA Research Foundation Name Governance Appointments
January 18, 2023 The Healthcare Distribution Alliance (HDA) and the HDA Research Foundation today announce the following governance updates.First, HDA appointed two new members to its Executive Committee and Board of Directors:
- Debbie Weitzman, Chief Executive Officer, Pharmaceutical Segment, Cardinal Health, Inc.; and,
- Rich Tremonte, EVP and President, US Pharmaceuticals & Animal Health, AmerisourceBergen Corporation.
“I welcome Debbie and Rich into their new roles, while thanking Bob for his years of service to HDA and the industry,” said Chester “Chip” Davis, Jr., President and CEO, HDA. “I look forward to working with the full Board of Directors as we execute against HDA’s strategic priorities. Working together, we will help ensure the safe and reliable distribution of medicines, vaccines and healthcare products to all Americans.”
The HDA Board of Directors is led by Chairman Chad Gielen of Louisiana Wholesale Drug Company and Vice Chairman Kirk Kaminsky of McKesson. View a full list of HDA directors here.
Second, the HDA Executive Committee approved four new appointments to the HDA Research Foundation Board of Directors:
- Bob Fasola, Vice President, Trade and Distribution Accounts, Takeda Pharmaceuticals America, Inc.;
- Resa Gilmore, Executive Director, National Supply and Care Delivery, Genentech, A Member of the Roche Group;
- Clint Syvinski, Co-CEO/Chief Operating Officer, Mutual Drug; and,
- Heather Zenk, RPh, PharmD, President, US Supply Chain, AmerisourceBergen Corporation.
Craig Cowman, Executive Vice President, Strategic Sourcing and Manufacturer Services, Cardinal Health, will continue as the HDA Research Foundation’s Chairman in 2023, with Steve Giuli, Vice President, Government Affairs and Trade Relations, Apotex Corp., serving as Vice Chairman. View a full list of Foundation directors here.
ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.
ABOUT THE HDA RESEARCH FOUNDATION
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization of the Healthcare Distribution Alliance (HDA). The Foundation serves as the thought leader in driving research, education and discussion for all healthcare supply chain stakeholders, enabling the industry's ability to deliver efficient, safe and secure patient access to medicines and medical products. Learn more at HDA.org/Foundation.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.
ABOUT THE HDA RESEARCH FOUNDATION
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization of the Healthcare Distribution Alliance (HDA). The Foundation serves as the thought leader in driving research, education and discussion for all healthcare supply chain stakeholders, enabling the industry's ability to deliver efficient, safe and secure patient access to medicines and medical products. Learn more at HDA.org/Foundation.